MG

Manjula Govindasamy

Active Director Director DIN 07598655
DIN 07598655 First appointment Sep 2016 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Manjula Govindasamy

Data last updated:

Manjula Govindasamy is a Director at Mirich Biocare India Private Limited (since 2016). The company operates in Food And Beverages.

DIN 07598655
Primary Designation Director
Industry Food And Beverages
First Appointment 05 Sep 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mirich Biocare India Private Limited U15549TZ2016PTC027969
Director05 Sep 20162016Active

Board colleagues of Manjula Govindasamy

NameDINCompanyDesignation
Rajkumar Radhkrishnan06984220Mirich Biocare India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mirich Biocare India Private Limited
Premium access

Shareholding and investment profile for Manjula Govindasamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manjula Govindasamy

Manjula Govindasamy currently holds 1 directorship: Mirich Biocare India Private Limited (Director, since 05 Sep 2016).

Manjula Govindasamy was first appointed on 05 Sep 2016 as Director at Mirich Biocare India Private Limited.

The current boards of Manjula Govindasamy's companies include Rajkumar Radhkrishnan (Mirich Biocare India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available